Fig. 5From: Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumorsDorsal view gamma camera images obtained 6 h post injection. Subcutaneous tumors in the right thigh are indicated. The BN8 derivative shows the best contrast of tumor uptake compared to other organs (mice are M5, M14, M29, and M33)Back to article page